The International Trade Commission has upheld its ruling that Apple infringed on AliveCor's heart rate monitoring patents. President Biden has pledged to review the ruling within 60 days and make a final decision by February 12.
See also: Apple: Will it delay the release of the iPhone SE 4?
The International Trade Commission (ITC) has suspended enforcement of the ruling, pending AliveCor's appeal of the U.S. Patent Trial and Appeal Board's December decision that invalidated three patents.
It is not at all certain that the president will agree to the mandate.
See also: Newer Apple Watches have improved battery life
In addition to this case, AliveCor is filing a damages lawsuit against Apple in the Northern District of California, with trial scheduled for early 2024.
For years, the two companies have been fiercely competing for dominance in ECG technologies, which are used by both the Apple Watch and the KardiaBand. Both sides accuse each other of infringing on their respective patents.
In May 2021, AliveCor filed a lawsuit against Apple for its alleged anti-competitive practices by disabling the previously approved AliveCor app
See also: Apple updated the Shortcuts app
On December 2, Apple filed a patent infringement lawsuit against AliveCor, alleging that four of its patents were infringed.
The case raises several important issues regarding intellectual property rights in today's digital age. This case demonstrates how companies must be vigilant about their intellectual property rights, especially when dealing with larger companies like Apple, which may have access to more resources than smaller companies.
Information source: appleinsider.com
